Gemifloxacin long-term outcomes in bronchitis exacerbations (GLOBE) study - An assessment of health outcome benefits in aecb patients following 5 days' gemifloxacin (GEMI) therapy Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

publication date

  • June 1, 2001